Spinout from Lexington's Agenus raises $40M in IPO

While MiNK Therapeutics Inc. is incorporated in New York City, half of employees and its main operations will be primarily based in Lexington, according to a company spokeswoman.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.